| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10be041e90fda03044defd75eb04c0fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfdf212f040e420dde6b5e74de04052d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d82007e7ef04bf533601371861d57ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95f587ce0d8dbb153d3ec793cf5d3dd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_990eb485260a14005a0f498717fab73e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 |
| filingDate |
2004-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35d6f900f7a19010e9c1978174eb88f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4c174b6840c82394e3d3c03520209f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e57f1ef0ee6907bf045bb4ac9455fff2 |
| publicationDate |
2005-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004082822-A3 |
| titleOfInvention |
Methods for isolating crystalline form i of 5-azacytidine |
| abstract |
The invention includes methods for isolating crystalline Form I of 5-azacytidine substantially free of other forms, wherein 5-azacytidine is represented by the formula: The invention also includes pharmaceutical compositions comprising Form I of 5-azacytidine. |
| priorityDate |
2003-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |